These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 19192637)

  • 1. Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors.
    Poggi G; Quaretti P; Minoia C; Bernardo G; Bonora MR; Gaggeri R; Ronchi A; Saluzzo CM; Azzaretti A; Rodolico G; Montagna M; Amatu A; Teragni C; Palumbo I; Traverso E; Tonini S; Villani L; Scelsi M; Baiardi P; Felisi MG; Sottotetti F; Tagliaferri B; Riccardi A
    Anticancer Res; 2008; 28(6B):3835-42. PubMed ID: 19192637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma.
    Poggi G; Amatu A; Montagna B; Quaretti P; Minoia C; Sottani C; Villani L; Tagliaferri B; Sottotetti F; Rossi O; Pozzi E; Zappoli F; Riccardi A; Bernardo G
    Cardiovasc Intervent Radiol; 2009 Nov; 32(6):1187-92. PubMed ID: 19727937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy.
    Kuhlmann JB; Euringer W; Spangenberg HC; Breidert M; Blum HE; Harder J; Fischer R
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):437-43. PubMed ID: 22261548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching the loaded agent from epirubicin to cisplatin: salvage transcatheter arterial chemoembolization with drug-eluting microspheres for unresectable hepatocellular carcinoma.
    Seki A; Hori S
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):555-62. PubMed ID: 21562932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience.
    Gusani NJ; Balaa FK; Steel JL; Geller DA; Marsh JW; Zajko AB; Carr BI; Gamblin TC
    J Gastrointest Surg; 2008 Jan; 12(1):129-37. PubMed ID: 17851723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxaliplatin-eluting microspheres for the treatment of intrahepatic cholangiocarcinoma: a case report.
    Poggi G; Quaretti P; Minoia C; Palumbo I; Villani L; Amatu A; Teragni C; Scelsi M; Zappoli F; Bernardo G
    Anticancer Res; 2008; 28(5B):2987-90. PubMed ID: 19031944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results.
    de Baere T; Deschamps F; Teriitheau C; Rao P; Conengrapht K; Schlumberger M; Leboulleux S; Baudin E; Hechellhammer L
    J Vasc Interv Radiol; 2008 Jun; 19(6):855-61. PubMed ID: 18503899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter arterial chemoembolization (TACE) of colorectal cancer liver metastases by irinotecan-eluting microspheres in a salvage patient population.
    Huppert P; Wenzel T; Wietholtz H
    Cardiovasc Intervent Radiol; 2014 Feb; 37(1):154-64. PubMed ID: 23670568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads: preliminary results.
    Aliberti C; Benea G; Tilli M; Fiorentini G
    Cardiovasc Intervent Radiol; 2008; 31(5):883-8. PubMed ID: 18478290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxaliplatin and 5-fluorouracil hepatic infusion with lipiodolized chemoembolization in large hepatocellular carcinoma.
    Li JH; Xie XY; Zhang L; Le F; Ge NL; Li LX; Gan YH; Chen Y; Zhang JB; Xue TC; Chen RX; Xia JL; Zhang BH; Ye SL; Wang YH; Ren ZG
    World J Gastroenterol; 2015 Apr; 21(13):3970-7. PubMed ID: 25852283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Previous chemoembolization response after transcatheter arterial chemoembolization (TACE) can predict the anti-tumor effect of subsequent TACE with miriplatin in patients with recurrent hepatocellular carcinoma.
    Imai N; Ikeda K; Seko Y; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
    Oncology; 2011; 80(3-4):188-94. PubMed ID: 21709428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute thrombocytopenia: an unusual complication occurring after drug-eluting microspheres transcatheter hepatic chemoembolization.
    Poggi G; Quaretti P; Montagna B; Sottotetti F; Tagliaferri B; Pozzi E; Amatu A; Pagella C; Bernardo G
    Cardiovasc Intervent Radiol; 2011 Feb; 34 Suppl 2():S190-4. PubMed ID: 20848100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study.
    He MK; Le Y; Li QJ; Yu ZS; Li SH; Wei W; Guo RP; Shi M
    Chin J Cancer; 2017 Oct; 36(1):83. PubMed ID: 29061175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead.
    Poon RT; Tso WK; Pang RW; Ng KK; Woo R; Tai KS; Fan ST
    Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1100-8. PubMed ID: 17627902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoembolization with Drug-eluting Microspheres Loaded with Doxorubicin for the Treatment of Cholangiocarcinoma.
    Aliberti C; Carandina R; Sarti D; Pizzirani E; Ramondo G; Mulazzani L; Mattioli GM; Fiorentini G
    Anticancer Res; 2017 Apr; 37(4):1859-1863. PubMed ID: 28373452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized phase II study of drug-eluting beads versus transarterial chemoembolization for unresectable hepatocellular carcinoma.
    van Malenstein H; Maleux G; Vandecaveye V; Heye S; Laleman W; van Pelt J; Vaninbroukx J; Nevens F; Verslype C
    Onkologie; 2011; 34(7):368-76. PubMed ID: 21734423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant TACE before laser induced thermotherapy (LITT) in the treatment of non-colorectal non-breast cancer liver metastases: feasibility and survival rates.
    Vogl TJ; Kreutzträger M; Gruber-Rouh T; Eichler K; Nour-Eldin NE; Zangos S; Naguib NN
    Eur J Radiol; 2014 Oct; 83(10):1804-10. PubMed ID: 25082479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective TACE with irinotecan-loaded 40 μm microspheres and FOLFIRI for colorectal liver metastases: phase I dose escalation pharmacokinetic study.
    Tanaka T; Sato T; Nishiofuku H; Masada T; Tatsumoto S; Marugami N; Otsuji T; Kanno M; Koyama F; Sho M; Kichikawa K
    BMC Cancer; 2019 Aug; 19(1):758. PubMed ID: 31370815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transarterial chemoembolization is a safe treatment for unresectable hepatic malignancies.
    Lopez RR; Pan SH; Lois JF; McMonigle ME; Hoffman AL; Sher LS; Lugo D; Makowka L
    Am Surg; 1997 Oct; 63(10):923-6. PubMed ID: 9322674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres: preliminary results from an Italian multicentre study.
    Grosso M; Vignali C; Quaretti P; Nicolini A; Melchiorre F; Gallarato G; Bargellini I; Petruzzi P; Massa Saluzzo C; Crespi S; Sarti I
    Cardiovasc Intervent Radiol; 2008; 31(6):1141-9. PubMed ID: 18696150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.